The ASC fully supports the use of HPV vaccines. We encourage all women -- even if vaccinated -- to continue regular Pap tests screening for cervical cancer.
The types of HPV that the vaccine works against are responsible for only 70% of the cases of cervical cancer, and no one knows how long the immunity provided by the vaccine will last.
Regularly scheduled Pap tests are vitally important in the detection of cervical cancer and routine testing should continue based upon established screening intervals.
Approved by the ASC Executive Board, March, 2007
|
HPV Resources can be found here |
Annual Scientific Meeting
Join the more than 800 attendees to learn the newest information and technology in ...
eJournal
We are proud to offer you the only online cytology journal club that reviews the most current ...
Case Studies
Case Studies provide an interactive distance-learning experience to interesting cases...
PEC
The Progressive Evaluation of Competency (PEC) is designed to track the progress of pathology residents & cytopathology fellows through the year...
Cytoteleconference
Designed with your convenience in mind, these 60-minute multi-media teleconferences address...
Archived Cytoteleconferences
Earn CME any time and any place. The ASC provides selections of the Cytoteleconference Series as links.
Web Atlas Bethesda System
Consisting of 349 images representing a range of morphologic findings the Web Atlas Bethesda System...
read more
